Gilead Sciences, Inc. - Common Stock (GILD) stock analysis
GILD · Gilead Sciences, Inc. - Common Stock
Latest recorded price: USD 167.58
Model-estimated fair value: USD 108.17. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Drug Manufacturers - General
At $167.58, GILD trades 54.9% above the model's base-case value of $108.17. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $82.64 in the conservative case and $136.71 in the optimistic case, with a valuation confidence score of 55/100. About 79% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 2.6%, free cash flow margin 32.1%, ROIC 18.6%. The model flags 1 risk signal for this company.